Lixte Biotechnology Inc. (LIXT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lixte Biotechnology Inc.

    NASDAQ: LIXT · Real-Time Price · USD
    4.33
    -0.24 (-5.25%)
    At close: Sep 08, 2025, 3:59 PM
    4.20
    -2.89%
    Pre-market: Sep 09, 2025, 06:51 AM EDT

    Lixte Biotechnology Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -3.57M -5.09M -6.31M -6.72M
    Interest Income
    		 7.05K 1.25K 11.2K 626.00
    Pretax Income
    		 -3.59M -5.09M -6.31M -6.73M
    Net Income
    		 -3.59M -5.09M -6.31M -6.73M
    Selling & General & Admin
    		 2.85M 4.19M 4.96M 4.98M
    Research & Development
    		 726.23K 898.1K 1.35M 1.74M
    Other Expenses
    		 -232 -100 n/a n/a
    Operating Expenses
    		 3.57M 5.09M 6.31M 6.72M
    Interest Expense
    		 n/a n/a 8.88K 7.41K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 3.57M 5.09M 6.31M 6.72M
    Income Tax Expense
    		 n/a n/a -7.82K 6.79K
    Shares Outstanding (Basic)
    		 2.25M 1.91M 1.58M 1.35M
    Shares Outstanding (Diluted)
    		 2.25M 1.92M 1.58M 1.35M
    EPS (Basic)
    		 -1.59 -2.66 -4 -5
    EPS (Diluted)
    		 -1.59 -2.66 -4 -5
    EBITDA
    		 -3.57M 3.21K -1.05K -7.95K
    EBIT
    		 -3.59M -5.09M -6.31M -6.73M
    Depreciation & Amortization
    		 30K 5.09M 6.31M 6.72M

    Add to Watchlist